UK markets closed

Everest Medicines Limited (6HN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.36000.0000 (0.00%)
As of 09:06AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-844,463
-844,463
-247,283
-1,008,719
-5,658,165
-
Depreciation & amortisation
76,776
76,776
42,772
31,124
20,395
-
Stock-based compensation
73,420
73,420
206,495
224,980
117,270
-
Change in working capital
-81,280
-81,280
-29,560
34,351
75,905
-
Inventory
-7,307
-7,307
-11,190
-447
0
-
Other working capital
-1,035,140
-1,035,140
-1,588,504
-1,705,752
-991,829
-
Other non-cash items
-84,750
-84,750
-32,887
-24,065
31,826
-
Net cash provided by operating activities
-769,190
-769,190
-1,155,761
-729,936
-471,899
-
Cash flows from investing activities
Investments in property, plant and equipment
-265,950
-265,950
-432,743
-975,816
-519,930
-
Acquisitions, net
-
-
-
-
0
-52,533
Purchases of investments
-3,533,293
-3,533,293
-1,160,588
0
-
-
Sales/maturities of investments
2,964,525
2,964,525
0
-
-
-
Other investing activities
6,195
6,195
-
-
-
-
Net cash used for investing activities
752,497
752,497
-1,028,025
-975,816
-519,930
-
Net change in cash
32,275
32,275
-2,149,265
-1,841,069
4,375,061
-
Cash at beginning of period
490,788
490,788
2,640,053
4,481,122
106,061
-
Cash at end of period
523,063
523,063
490,788
2,640,053
4,481,122
-
Free cash flow
Operating cash flow
-769,190
-769,190
-1,155,761
-729,936
-471,899
-
Capital expenditure
-265,950
-265,950
-432,743
-975,816
-519,930
-
Free cash flow
-1,035,140
-1,035,140
-1,588,504
-1,705,752
-991,829
-